Search research articles
Contact Us
Filters
Showing results (251-260 of 377) with videos related to
Page
of 38
Sort By:
Geburtshilfe Und Frauenheilkunde
|
June 21, 2019
Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019)
Michael Untch, Christoph Thomssen, Ingo Bauerfeind, et al.
JAMA Oncology
|
September 25, 2025
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial
Peter A Fasching, Daniil Stroyakovskiy, Denise A Yardley, et al.
Geburtshilfe Und Frauenheilkunde
|
February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer
Diana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Lancet (London, England)
|
January 9, 2007
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith, Marion Procter, Richard D Gelber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
Sibylle Loibl, Denise Treue, Jan Budczies, et al.
Virchows Archiv : an International Journal of Pathology
|
April 23, 2026
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification
Paul Jank, Maximilian J Krämer, Michael Untch, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2022
Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer
Bahriye Aktas, Tanja N Fehm, Manfred Welslau, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2022
Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer
Tanja N Fehm, Manfred Welslau, Volkmar Müller, et al.
NPJ Breast Cancer
|
April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Marion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Scientific Reports
|
September 12, 2025
Macrophage polarization is associated with postoperative seroma development in breast cancer in the SerMa pilot cohort
Felicitas Magdalena Schneider, Nicole Pochert, Fritzi Schittek, et al.
Page
of 38
Search research articles
Search
Showing results (251-260 of 377) with videos related to
Sort By:
Page
of 38
Geburtshilfe Und Frauenheilkunde
|
June 21, 2019
Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019)
Michael Untch, Christoph Thomssen, Ingo Bauerfeind, et al.
JAMA Oncology
|
September 25, 2025
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial
Peter A Fasching, Daniil Stroyakovskiy, Denise A Yardley, et al.
Geburtshilfe Und Frauenheilkunde
|
February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer
Diana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Lancet (London, England)
|
January 9, 2007
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith, Marion Procter, Richard D Gelber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
Sibylle Loibl, Denise Treue, Jan Budczies, et al.
Virchows Archiv : an International Journal of Pathology
|
April 23, 2026
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification
Paul Jank, Maximilian J Krämer, Michael Untch, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2022
Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer
Bahriye Aktas, Tanja N Fehm, Manfred Welslau, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2022
Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer
Tanja N Fehm, Manfred Welslau, Volkmar Müller, et al.
NPJ Breast Cancer
|
April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Marion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Scientific Reports
|
September 12, 2025
Macrophage polarization is associated with postoperative seroma development in breast cancer in the SerMa pilot cohort
Felicitas Magdalena Schneider, Nicole Pochert, Fritzi Schittek, et al.
Page
of 38